DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Kong G. et al.
Assessment of predictors of response and long-term survival of patients with neuroendocrine tumour treated with peptide receptor chemoradionuclide therapy (PRCRT).
Eur J Nucl Med Mol Imaging 2014;
41: 1831-1844
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.